Researchers dont know the exact causes of diverticulitis, but pressure in the digestive tract seems to contribute to the development of small pouches in the intestinal wall
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers
That alone can dramatically improve your results and energy
There is no clinical data on this combination, and it is generally not recommended because the GLP-1 receptor activation from multiple compounds would overlap, potentially increasing gastrointestinal side effects without proportional benefit
If skin pain, burning, or tingling start after moving up to a higher dose, your healthcare provider may recommend adjusting your treatment plan, especially if symptoms persist